25
Total deals
$75.0B
Total value
$3.4B
Avg deal
$39.0B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Modella AI
Modella AI is a health-care AI company that provides AI solutions to transform c…
|
2026-01-13 | Acquisition | Pending | — | Deal → |
| 2 |
SixPeaks Bio
SixPeaks Bio is developing a pipeline of medicines for healthy weight loss.
|
2025-11-10 | Acquisition | Pending | $300.0M | Deal → |
| 3 |
EsoBiotec
EsoBiotec is a Belgian biotechnology business focused on the discovery of novel …
|
2025-03-17 | Acquisition | Complete | $1.0B | Deal → |
| 4 |
F
FibroGen China
FibroGen China is committed to providing access to revolutionary medical treatme…
|
2025-02-20 | Acquisition | Complete | $220.0M | Deal → |
| 5 |
Fusion Pharmaceuticals
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developin…
|
2024-03-19 | Acquisition | Complete | $2.4B | Deal → |
| 6 |
Amolyt Pharma
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and me…
|
2024-03-14 | Acquisition | Complete | $1.1B | Deal → |
| 7 |
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to trea…
|
2024-02-22 | Acquisition | Complete | $1.2B | Deal → |
| 8 |
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious…
|
2023-12-12 | Acquisition | Complete | $1.1B | Deal → |
| 9 |
CinCor Pharma
CinCor is a clinical-stage biopharmaceutical company that develops treatments fo…
|
2023-01-09 | Acquisition | Complete | $1.8B | Deal → |
| 10 |
Neogene Therapeutics
Neogene Therapeutics is a biotech company providing cancer patients with T cell …
|
2022-11-29 | Acquisition | Complete | $320.0M | Deal → |
| 11 |
T
TeneoTwo
TeneoTwo is a biotechnology firm that develops potential new medicine for B-cell…
|
2022-07-05 | Acquisition | Complete | $100.0M | Deal → |
| 12 |
Caelum Biosciences
Caelum Biosciences, Inc.is a clinical-stage biotechnology company.
|
2021-09-29 | Acquisition | Complete | $500.0M | Deal → |
| 13 |
Alexion Pharmaceuticals
Alexion Pharmaceuticals is a biopharmaceutical company that engages in the devel…
|
2020-12-12 | Acquisition | Complete | $39.0B | Deal → |
| 14 |
Takeda Respiratory Business
Takeda Respiratory Business develops therapeutics.
|
2016-04-16 | Acquisition | Complete | $575.0M | Deal → |
| 15 |
AcertaPharma
Acerta Pharma provides drug discovery and development services for oncology and …
|
2015-12-17 | Acquisition | Complete | $4.0B | Deal → |
| 16 |
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medi…
|
2015-11-06 | Acquisition | Complete | $2.7B | Deal → |
| 17 |
Pearl Therapeutics
Pearl develops a combination of products for the treatment of respiratory diseas…
|
2013-06-10 | Acquisition | Complete | $1.1B | Deal → |
| 18 |
Omthera Pharmaceuticals
Omthera Pharmaceuticals develops therapies for patients with elevated triglyceri…
|
2013-05-29 | Acquisition | Complete | $323.0M | Deal → |
| 19 |
Ardea Biosciences
Ardea, headquartered in San Diego, California, is a biotechnology company focuse…
|
2012-04-23 | Acquisition | Complete | $781.0M | Deal → |
| 20 |
G
Guangdong BeiKang Pharmaceutical Company Ltd
Guangdong BeiKang Pharmaceutical Company Ltd manufactures drugs which includes g…
|
2011-12-08 | Acquisition | Complete | — | Deal → |
| 21 |
Novexel
Novexel, a pharmaceutical company, engages in the discovery and development of a…
|
2009-12-23 | Acquisition | Complete | — | Deal → |
| 22 |
MedImmune
MedImmune develops medicines for unmet medical needs worldwide.
|
2007-04-14 | Acquisition | Complete | $15.6B | Deal → |
| 23 |
Arrow Therapeutics
Arrow is a small pharmaceutical company strictly focussed on novel anti-infectiv…
|
2007-02-01 | Acquisition | Complete | $150.0M | Deal → |
| 24 |
C
Cambridge Antibody Technology
Cambridge Antibody Technology offers human monoclonal antibodies for therapeutic…
|
2006-05-18 | Acquisition | Complete | $567.0M | Deal → |
| 25 |
KuDOS Pharmaceuticals
KuDOS Pharmaceuticals Ltd discovers and develops drugs based upon the science of…
|
2005-12-23 | Acquisition | Complete | $210.0M | Deal → |